Ontology highlight
ABSTRACT:
SUBMITTER: Peethambaram PP
PROVIDER: S-EPMC5648884 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature
NPJ breast cancer 20171019
The 21-gene Recurrence Score (RS) assay is prognostic and predictive of adjuvant chemotherapy benefit in node positive (N+) breast cancer (BC). We sought to evaluate use patterns of RS assay in N+, ER+/HER2- BC and the impact of RS on recommendations for adjuvant chemotherapy. Patients with T1-T4c,N1mi-N3, ER+/HER2- BC diagnosed 2010-2013 in the National Cancer Database were analyzed. Multivariable logistic regression assessed factors influencing RS testing and chemotherapy recommendations based ...[more]